Sarah Dräger

612 total citations
24 papers, 402 citations indexed

About

Sarah Dräger is a scholar working on Epidemiology, Pharmacology and Infectious Diseases. According to data from OpenAlex, Sarah Dräger has authored 24 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 10 papers in Pharmacology and 9 papers in Infectious Diseases. Recurrent topics in Sarah Dräger's work include Antibiotics Pharmacokinetics and Efficacy (9 papers), Pneumonia and Respiratory Infections (7 papers) and Respiratory viral infections research (4 papers). Sarah Dräger is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (9 papers), Pneumonia and Respiratory Infections (7 papers) and Respiratory viral infections research (4 papers). Sarah Dräger collaborates with scholars based in Switzerland, Netherlands and Germany. Sarah Dräger's co-authors include Elizabeth J. Robertson, Ita Costello, Elizabeth K. Bikoff, Sebastian J. Arnold, Katja de With, Julia Draf, Thomas Hummel, Antje Haehner, Richard S. Lefleur and H. Leon Pachter and has published in prestigious journals such as Nature Cell Biology, Clinical Infectious Diseases and Journal of Clinical Microbiology.

In The Last Decade

Sarah Dräger

17 papers receiving 390 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sarah Dräger Switzerland 7 190 86 70 62 60 24 402
S Christie United Kingdom 8 56 0.3× 38 0.4× 20 0.3× 86 1.4× 19 0.3× 13 381
Richard P. Rood United States 11 192 1.0× 11 0.1× 103 1.5× 91 1.5× 6 0.1× 18 423
Hugo Y. Hsu United States 16 45 0.2× 13 0.2× 90 1.3× 118 1.9× 11 0.2× 36 714
Miguel Ortiz United States 5 62 0.3× 29 0.3× 23 0.3× 47 0.8× 28 0.5× 9 479
Vladimir Bedeković Croatia 7 74 0.4× 22 0.3× 70 1.0× 22 0.4× 4 0.1× 36 309
Yamazaki Japan 10 61 0.3× 11 0.1× 83 1.2× 29 0.5× 38 0.6× 18 343
Ranjanie Gamage Sri Lanka 11 24 0.1× 33 0.4× 58 0.8× 22 0.4× 22 0.4× 36 334
Ali Baykan Türkiye 8 38 0.2× 29 0.3× 96 1.4× 38 0.6× 20 0.3× 36 287
Yaling Liao China 9 219 1.2× 7 0.1× 34 0.5× 34 0.5× 17 0.3× 22 377
Vesa-Matti Loitto Sweden 7 149 0.8× 8 0.1× 45 0.6× 23 0.4× 19 0.3× 8 357

Countries citing papers authored by Sarah Dräger

Since Specialization
Citations

This map shows the geographic impact of Sarah Dräger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Dräger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Dräger more than expected).

Fields of papers citing papers by Sarah Dräger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Dräger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Dräger. The network helps show where Sarah Dräger may publish in the future.

Co-authorship network of co-authors of Sarah Dräger

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Dräger. A scholar is included among the top collaborators of Sarah Dräger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Dräger. Sarah Dräger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Dräger, Sarah, Iris K. Minichmayr, Narges Alipanah, et al.. (2025). Dose individualisation of antibiotics in critically ill patients with inflammation: A narrative review. British Journal of Clinical Pharmacology. 91(11). 3042–3053.
3.
Gosert, Rainer, Klaudia Naegele, M.M. Weiss, et al.. (2025). Rebound of Respiratory Virus Activity and Seasonality to Pre‐Pandemic Patterns. Journal of Medical Virology. 97(11). e70658–e70658.
4.
Dräger, Sarah, M Bernasconi, Vlastimil Jirasko, et al.. (2024). Impact of Swabbing Location, Self-Swabbing, and Food Intake on SARS-CoV-2 RNA Detection. Microorganisms. 12(3). 591–591. 2 indexed citations
5.
Schöning, Verena, Sarah Dräger, Katharina Rentsch, et al.. (2024). Population pharmacokinetics of flucloxacillin as intermittent bolus infusion in patients with Staphylococcus aureus bloodstream infection. Journal of Antimicrobial Chemotherapy. 79(8). 2031–2039.
6.
Jirasko, Vlastimil, et al.. (2024). Iodide based electrochemical gold quantification method for lateral flow assays. Biosensors and Bioelectronics. 262. 116524–116524.
7.
8.
Gosert, Rainer, Sarah Dräger, Alban Ramette, et al.. (2024). Multicenter Evaluation of the QIAstat‐Dx and the BioFire Multiplex Panel Tests for the Detection of Respiratory Pathogens. Journal of Medical Virology. 96(12). e70129–e70129. 4 indexed citations
9.
Dräger, Sarah, Tim M. J. Ewoldt, Alan Abdulla, et al.. (2024). Target attainment of beta-lactam antibiotics and ciprofloxacin in critically ill patients and its association with 28-day mortality. Journal of Critical Care. 85. 154904–154904. 2 indexed citations
10.
Dräger, Sarah, Tim M. J. Ewoldt, Alan Abdulla, et al.. (2024). Exploring the Impact of Model-Informed Precision Dosing on Procalcitonin Concentrations in Critically Ill Patients: A Secondary Analysis of the DOLPHIN Trial. Pharmaceutics. 16(2). 270–270. 1 indexed citations
11.
Dräger, Sarah, Niklaus Daniel Labhardt, Martin Siegemund, et al.. (2023). Early Target Attainment With Continuous Infusion Meropenem and Piperacillin/Tazobactam and Utilization of Therapeutic Drug Monitoring in Critically Ill Patients: A Retrospective Cohort Study From 2017 to 2020. Open Forum Infectious Diseases. 10(4). ofad143–ofad143. 6 indexed citations
12.
Rietdijk, Wim J. R., Sarah Dräger, Henrik Endeman, & Birgit C. P. Koch. (2023). Beta-lactam Therapeutic Drug Monitoring in Critically ill Patients: Learnings for Future Research. Clinical Infectious Diseases. 77(4). 663–664. 4 indexed citations
13.
14.
Dräger, Sarah, et al.. (2022). Antibiotic treatment duration in diverticulitis, complicated urinary tract infection, and endocarditis: a retrospective, single-center study. International Journal of Infectious Diseases. 124. 89–95. 1 indexed citations
15.
Dräger, Sarah, et al.. (2022). Antibiotic treatment durations for common infectious diseases in Switzerland: comparison between real-life and local and international guideline recommendations. Journal of Global Antimicrobial Resistance. 32. 11–17. 4 indexed citations
16.
17.
Dräger, Sarah, et al.. (2020). Relevance of Dermabacter hominis isolated from clinical samples, 2012–2016: a retrospective case series. Diagnostic Microbiology and Infectious Disease. 98(2). 115118–115118. 3 indexed citations
18.
Haehner, Antje, Julia Draf, Sarah Dräger, Katja de With, & Thomas Hummel. (2020). Predictive Value of Sudden Olfactory Loss in the Diagnosis of COVID-19. ORL. 82(4). 175–180. 110 indexed citations
19.
Dräger, Sarah, Anna‐Friederike Marx, Fiona Pigny, et al.. (2019). Lymphocytic choriomeningitis virus meningitis after needlestick injury: a case report. Antimicrobial Resistance and Infection Control. 8(1). 77–77. 6 indexed citations
20.
Costello, Ita, et al.. (2011). The T-box transcription factor Eomesodermin acts upstream of Mesp1 to specify cardiac mesoderm during mouse gastrulation. Nature Cell Biology. 13(9). 1084–1091. 191 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S Christie Breakdown of academic impact, for papers by Richard P. Rood Breakdown of academic impact, for papers by Hugo Y. Hsu Breakdown of academic impact, for papers by Miguel Ortiz Breakdown of academic impact, for papers by Vladimir Bedeković Breakdown of academic impact, for papers by Yamazaki Breakdown of academic impact, for papers by Ranjanie Gamage Breakdown of academic impact, for papers by Ali Baykan Breakdown of academic impact, for papers by Yaling Liao Breakdown of academic impact, for papers by Vesa-Matti Loitto
Rankless by CCL
2026